J&J Wins Jury Verdict Against Boston Scientific In Stents Patent Battle

Law360, New York (June 22, 2005, 12:00 AM EDT) -- A federal jury in Delaware has found that Boston Scientific Corp. infringed patents held by rival Johnson & Johnson in a closely watched jury trial over drug-coated stents.

On Tuesday, the Delaware jury found that Boston Scientific's Taxus drug-eluting stent and its Liberte and Express bare-metal stents infringed J&J's core Palmaz patent for balloon expandable stents.

The jury also found the Liberte stent infringed another patent, called the Gray patent, that covers flexible stent technology and expires in 2016.

Boston Scientific had challenged the validity of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.